Practical vs Recent Clinical Trial Use Of Dalbavancin - Poll - MDSpire

Practical vs Recent Clinical Trial Use Of Dalbavancin

  • By

  • Sarah A. Uhm

  • Bryan T. Alexander

  • Elizabeth R. Lyden

  • Nicolas Cortes-Penfield

  • Harlan R. Sayles

  • Sara F. Azimi

  • Mackenzie R. Keintz

  • Molly M. Miller

  • Mark E. Rupp

  • Jasmine R. Marcelin

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Practical vs Recent Clinical Trial Use Of Dalbavancin

  • by Sarah A. Uhm, Bryan T. Alexander, Elizabeth R. Lyden, Nicolas Cortes-Penfield, Harlan R. Sayles, Sara F. Azimi, Mackenzie R. Keintz, Molly M. Miller, Mark E. Rupp, Jasmine R. Marcelin

  • June 3, 2026

Related Content

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks

Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

  • June 2, 2026

  • 5 min